Rx360 $16B Platform Play: Medication Adherence Wearable Across MTM and Adjacent Clinical Programs¶

Format: PDF

Overview¶

This document outlines the total addressable market opportunity for Rx360 as a medication adherence wearable platform, anchored in Medication Therapy Management and expanded across adjacent clinical programs. It frames Rx360's growth trajectory from MTM/CMR into a multi-program platform play valued at $16 billion.

Key Topics¶

Total addressable market sizing for medication adherence wearables
Medication Therapy Management (MTM) and Comprehensive Medication Review (CMR) opportunity
Adjacent clinical programs and expansion pathways
Platform strategy and multi-program integration
Payer, health system, and pharmacy partner market segments
Revenue model and scaling assumptions